Sildenafil use in a symptomatic neonate with severe Ebstein's anomaly of the tricuspid valve

Research output: Contribution to journalArticlepeer-review

Abstract

Ebstein's anomaly (EA) is associated with poor outcome in symptomatic neonates. Management typically includes prostaglandins or surgical creation of a Blalock-Taussig shunt. Right ventricular afterload reduction may help by improving the forward flow across the pulmonary valve. We report the successful use of oral sildenafil, a pulmonary vasodilator, in a neonate with severe EA.

Original languageEnglish
Pages (from-to)125-128
Number of pages4
JournalAmerican Journal of Perinatology
Volume25
Issue number2
DOIs
StatePublished - Feb 2008

Keywords

  • Cyanosis
  • Ebstein's anomaly
  • Neonate
  • Sildenafil

Fingerprint

Dive into the research topics of 'Sildenafil use in a symptomatic neonate with severe Ebstein's anomaly of the tricuspid valve'. Together they form a unique fingerprint.

Cite this